Status and phase
Conditions
Treatments
About
The primary objective of this open label extension study is to evaluate the long-term safety and tolerability of maralixibat.
Full description
The study will be conducted at multiple sites in North America, Europe, Asia, and South America.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
90 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal